CHANGE IN RATINGS

Alcoa

(AA) - Get Report

downgraded at Deutsche Bank to Sell from Hold and price target cut to $8 from $10.

Burlington Northern

(BNI)

downgraded at Morgan Stanley from Equal-weight to Underweight. Industry traffic is expected to fall 7.5%-9% in the fourth quarter.

Commerce Bancshares

(CBSH) - Get Report

upgraded at Barclays to Overweight from Equal-weight. Price target at $42.

Cullen/Frost Bankers

(CFR) - Get Report

upgraded at Barclays to Overweight from Equal-weight. Price target lowered to $50 from $55.

France Telecom

(FTE)

downgraded at Credit Suisse to Underperform. Price target lowered to $21 from $24.

Harley-Davidson

(HOG) - Get Report

downgraded at Goldman Sachs to Sell from Neutral based on additional downside potential. Price target cut to $30 from $11.

Hologic

(HOLX) - Get Report

upgraded at Jefferies to a Buy from Hold. Price target increased to $14 from $10.90.

Palm

(PALM)

upgraded at Citigroup from Sell to Hold. New Pre smartphone has the ability to be a blockbuster. $6.50 price target.

Pfizer

(PFE) - Get Report

upgraded at Goldman Sachs to Neutral from Sell following recent underperformance vs. other large-cap pharma. Price target unchanged at $19.

Polaris Industries

(PII) - Get Report

downgraded at Citigroup from Buy to Hold. $29 price target. Estimates also cut.

STOCK COMMENTS / EPS CHANGES

Activision

(ATVI) - Get Report

added to Top Picks list at Citigroup. $15 price target. Buy rating.

Clorox

(CLX) - Get Report

numbers lowered at Barclays. Shares now seen reaching $49. Estimates also cut. Underweight rating.

CME Group

(CME) - Get Report

price target cut at Credit Suisse to $275 from $350 based on volume declines. Maintained Outperform rating.

CVS Caremark

(CVS) - Get Report

numbers lowered at Morgan Stanley. Shares now seen reaching $36. Estimates also cut, to match the company's new lower guidance for the PBM business. Overweight rating.

McKesson

(MCK) - Get Report

numbers cut at Barclays. Shares expected to see $51. Estimates also lowered to reflect lower hospital spending. Overweight rating.

Qualcomm

(QCOM) - Get Report

estimates cut at Merrill/BofA to reflect tighter 3G chipset inventories. Company remains positioned well. Buy rating and $42 price target.

Charles Schwab

(SCHW) - Get Report

target lowered at Credit Suisse to $19 from $21. Maintained Outperform rating.

STRATEGY CALLS / MARKET CALLS

Estimates and price targets were cut for

Linear Technology

(LLTC)

,

Marvell

(MRVL) - Get Report

,

Nvidia

(NVDA) - Get Report

and

Xilinx

(XLNX) - Get Report

, according to Barclays Capital. Companies seeing weak end-market demand and will likely post weak near-term results.

This article was written by a staff member of TheStreet.com.